BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35526251)

  • 1. Notch1 signaling modulates hypoxia-induced multidrug resistance in human laryngeal cancer cells.
    Li D; Xu D; Chen P; Xie J
    Mol Biol Rep; 2022 Jul; 49(7):6235-6240. PubMed ID: 35526251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Notch1 signaling on cellular proliferation and apoptosis in human laryngeal carcinoma.
    Li D; Xu D; Zhang Y; Chen P; Xie J
    World J Surg Oncol; 2022 Aug; 20(1):262. PubMed ID: 35982489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect and Mechanism of Survivin on Hypoxia-Induced Multidrug Resistance of Human Laryngeal Carcinoma Cells.
    Xu D; Li DW; Xie J; Chen XW
    Biomed Res Int; 2019; 2019():5696801. PubMed ID: 31179330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of multidrug resistance 1/P-glycoprotein on the hypoxia-induced multidrug resistance of human laryngeal cancer cells.
    Li D; Zhou L; Huang J; Xiao X
    Oncol Lett; 2016 Aug; 12(2):1569-1574. PubMed ID: 27446473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notch1 is associated with the multidrug resistance of hypoxic osteosarcoma by regulating MRP1 gene expression.
    Li C; Guo D; Tang B; Zhang Y; Zhang K; Nie L
    Neoplasma; 2016; 63(5):734-42. PubMed ID: 27468877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIF-1α inhibition reverses multidrug resistance in colon cancer cells via downregulation of MDR1/P-glycoprotein.
    Chen J; Ding Z; Peng Y; Pan F; Li J; Zou L; Zhang Y; Liang H
    PLoS One; 2014; 9(6):e98882. PubMed ID: 24901645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia induced multidrug resistance of laryngeal cancer cells via hypoxia-inducible factor-1α.
    Li DW; Dong P; Wang F; Chen XW; Xu CZ; Zhou L
    Asian Pac J Cancer Prev; 2013; 14(8):4853-8. PubMed ID: 24083758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reverse multidrug resistance in laryngeal cancer cells by knockdown MDR1 gene expression.
    Zhigang H; Qi Z; Jugao F; Xiaohong C; Wei Z; Hong W; Hu H; Na M; Zheng Y; Demin H
    J Otolaryngol Head Neck Surg; 2009 Aug; 38(4):440-8. PubMed ID: 19755084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-fos upregulates P-glycoprotein, contributing to the development of multidrug resistance in HEp-2 laryngeal cancer cells with VCR-induced resistance.
    Li G; Hu X; Sun L; Li X; Li J; Li T; Zhang X
    Cell Mol Biol Lett; 2018; 23():6. PubMed ID: 29483928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Notch-1 signaling facilitates survivin expression in human non-small cell lung cancer cells.
    Chen Y; Li D; Liu H; Xu H; Zheng H; Qian F; Li W; Zhao C; Wang Z; Wang X
    Cancer Biol Ther; 2011 Jan; 11(1):14-21. PubMed ID: 20962575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetrandrine partially reverses multidrug resistance of human laryngeal cancer cells.
    Li Y; Li D; Wang P; Zhu W; Yin W
    J Int Med Res; 2020 Aug; 48(8):300060520944706. PubMed ID: 32776811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of MDR1/P-glycoprotein-mediated multidrug resistance by vector-based RNA interference in vitro and in vivo.
    Shi Z; Liang YJ; Chen ZS; Wang XW; Wang XH; Ding Y; Chen LM; Yang XP; Fu LW
    Cancer Biol Ther; 2006 Jan; 5(1):39-47. PubMed ID: 16319528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notch1 is required for hypoxia-induced proliferation, invasion and chemoresistance of T-cell acute lymphoblastic leukemia cells.
    Zou J; Li P; Lu F; Liu N; Dai J; Ye J; Qu X; Sun X; Ma D; Park J; Ji C
    J Hematol Oncol; 2013 Jan; 6():3. PubMed ID: 23289374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells.
    Liu F; Liu S; He S; Xie Z; Zu X; Jiang Y
    Oncol Rep; 2010 May; 23(5):1469-75. PubMed ID: 20372866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth inhibitory effects of DJ-1-small interfering RNA on laryngeal carcinoma Hep-2 cells.
    Shen Z; Jiang Z; Ye D; Xiao B; Zhang X; Guo J
    Med Oncol; 2011 Jun; 28(2):601-7. PubMed ID: 20300974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDR1/P-gp and VEGF synergistically enhance the invasion of Hep-2 cells with multidrug resistance induced by taxol.
    Li L; Jiang AC; Dong P; Wang H; Xu W; Xu C
    Ann Surg Oncol; 2009 May; 16(5):1421-8. PubMed ID: 19247716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and significance of hypoxia-inducible factor-1α and survivin in laryngeal carcinoma tissue and cells.
    Li DW; Zhou L; Jin B; Xie J; Dong P
    Otolaryngol Head Neck Surg; 2013 Jan; 148(1):75-81. PubMed ID: 23087365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [siRNA silences mdr1 gene expression and reverses apoptosis resistance of K562/ADM cells line].
    Wei HL; Gao LP; Jing T; Zhao HS; Yi J; Sun J; Han J
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jun; 28(6):388-90. PubMed ID: 17939404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential role of Notch1 signaling pathway in laryngeal squamous cell carcinoma cell line Hep-2 involving proliferation inhibition, cell cycle arrest, cell apoptosis, and cell migration.
    Jiao J; Qin Z; Li S; Liu H; Lu Z
    Oncol Rep; 2009 Oct; 22(4):815-23. PubMed ID: 19724860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA SNHG1 promotes cell proliferation in laryngeal cancer via Notch1 signaling pathway.
    Liu T; Zuo JJ; Li F; Xu YC; Zheng AY; Tao ZZ
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6562-6569. PubMed ID: 31378897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.